We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
-3.21%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$932M
AUM Growth
-$61.9M
Cap. Flow
-$9.52M
Cap. Flow %
-1.02%
Top 10 Hldgs %
29.97%
Holding
242
New
67
Increased
40
Reduced
47
Closed
40

Top Buys

Rank Stock Value
1
GD icon
General Dynamics
GD
+$26.9M
2
SNY icon
Sanofi
SNY
+$14.6M
3
VALE icon
Vale
VALE
+$13.4M
4
HE icon
Hawaiian Electric Industries
HE
+$12.2M
5
DXCM icon
DexCom
DXCM
+$12.1M

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$26.1M
2
BAX icon
Baxter International
BAX
+$14M
3
KMI icon
Kinder Morgan
KMI
+$13.2M
4
RCL icon
Royal Caribbean
RCL
+$10.7M
5
ILMN icon
Illumina
ILMN
+$10.3M

Sector Composition

Rank Sector Weight
1 Technology 16.94%
2 Healthcare 15.37%
3 Consumer Discretionary 14.32%
4 Energy 11.7%
5 Miscellaneous 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CXH
201
DELISTED
MFS Investment Grade Municipal Trust
CXH
$78.1K 0.01%
+11,048
New +$81.9K
MSD
202
Morgan Stanley Emerging Markets Debt Fund
MSD
$143M
$68.1K 0.01%
10,500
AGD
203
abrdn Global Dynamic Dividend Fund
AGD
$308M
-36,927
Closed -$352K
APLS
204
DELISTED
Apellis Pharmaceuticals
APLS
-83,679
Closed -$7.62M
ASND icon
205
Ascendis Pharma A/S
ASND
$16.2B
-51,200
Closed -$4.57M
BAX icon
206
Baxter International
BAX
$12.3B
-308,178
Closed -$14M
BMY icon
207
Bristol-Myers Squibb
BMY
$131B
-37,700
Closed -$2.41M
BSTZ icon
208
BlackRock Science and Technology Term Trust
BSTZ
$1.94B
-247,940
Closed -$4.49M
BXMT icon
209
Blackstone Mortgage Trust
BXMT
$2.26B
-148,603
Closed -$3.09M
BXSL icon
210
Blackstone Secured Lending
BXSL
$5.8B
-178,500
Closed -$4.88M
CCI icon
211
Crown Castle
CCI
$31.7B
-17,290
Closed -$1.97M
CLM icon
212
Cornerstone Strategic Value Fund
CLM
$1.95B
-16,358
Closed -$135K
CMA
213
DELISTED
Comerica
CMA
-168,700
Closed -$7.15M
CRF
214
Cornerstone Total Return Fund
CRF
$1.03B
-17,136
Closed -$134K
CRSP icon
215
CRISPR Therapeutics
CRSP
$5.11B
-56,969
Closed -$3.2M
DIS icon
216
Walt Disney
DIS
$186B
-40,300
Closed -$3.6M
EVF
217
Eaton Vance Senior Income Trust
EVF
$88.5M
-88,164
Closed -$481K
GBDC icon
218
Golub Capital BDC
GBDC
$3.25B
-49,840
Closed -$673K
HEQ
219
John Hancock Hedged Equity & Income Fund
HEQ
$136M
-59,800
Closed -$645K
ILMN icon
220
Illumina
ILMN
$34.8B
-56,427
Closed -$10.3M
KEY icon
221
KeyCorp
KEY
$22.9B
-610,600
Closed -$5.64M
KMI icon
222
Kinder Morgan
KMI
$68.9B
-766,112
Closed -$13.2M
LEGN icon
223
Legend Biotech
LEGN
$3.33B
-41,100
Closed -$2.84M
MCHI icon
224
iShares MSCI China ETF
MCHI
$6.06B
-73,900
Closed -$3.31M
MET icon
225
MetLife
MET
$62.4B
-86,900
Closed -$4.91M

Similar funds

Clough Capital Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Clough Capital Partners held 242 positions worth $932M, down 6.2% from $994M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Clough Capital Partners's Q3 2023 filing shows 67 new, 40 increased, 47 reduced and 40 closed positions. Its largest new stake was General Dynamics: 121,590 shares worth $26.9M. The largest sale was RTX Corp, an estimated $26.1M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Clough Capital Partners's largest Q3 2023 buy was General Dynamics: 121,590 shares worth $26.9M.
  • Clough Capital Partners added most to Microsoft in Q3 2023, an estimated $11.4M increase.
  • Clough Capital Partners's biggest Q3 2023 reduction was Royal Caribbean, cutting an estimated $10.7M.
  • Clough Capital Partners fully exited RTX Corp in Q3 2023, selling an estimated $26.1M.
  • Clough Capital Partners's ten largest holdings make up 30% of its $932M portfolio in Q3 2023.
  • Clough Capital Partners opened 67 new positions and closed 40 in Q3 2023.
  • Clough Capital Partners's portfolio value fell 6.2% quarter-over-quarter to $932M.

Based on Clough Capital Partners's 13F filing for Q3 2023, filed 14 Nov 2023.